Clinical trials
Phase 2/3 Inflammation trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 3 |
| 2011 | 3 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 1 |
| 2020 | 3 |
| 2021 | 1 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Terminated | 3 |
| Active, not recruiting | 2 |
| Withdrawn | 2 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Joslin Diabetes Center | 3 |
| ARCA Biopharma, Inc. | 1 |
| Ashibio Inc | 1 |
| Biomedical Enterprises Inc | 1 |
| Cedars-Sinai Medical Center | 1 |
| Columbia University | 1 |
| Laurent Pharmaceuticals Inc. | 1 |
| Massachusetts General Hospital | 1 |
| Medical College of Wisconsin | 1 |
| Nathan Kline Institute for Psychiatric Research | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Inflammation | 23 |
| Metabolic Syndrome | 4 |
| COVID-19 | 3 |
| Diabetes Mellitus, Type 2 | 3 |
| Obesity | 3 |
| Overweight | 3 |
| Atherosclerosis | 2 |
| Anxiety Disorders | 1 |
| Arthralgia | 1 |
| Arthritis | 1 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.